ZELNORM

This brand name is authorized in United States. It is also authorized in Estonia.

Active ingredients

The drug ZELNORM contains one active pharmaceutical ingredient (API):

1	Tegaserod UNII 458VC51857 - TEGASEROD
	Tegaserod is an agonist of serotonin type-4 (5-HT4) receptors that stimulates the peristaltic reflex and intestinal secretion, inhibits visceral sensitivity, enhances basal motor activity, and normalizes impaired motility throughout the gastrointestinal tract.
	Read more about Tegaserod

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZELNORM Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AX06		A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AX Other laxatives
Discover more medicines within A06AX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1872941
US	FDA, National Drug Code	0525-0971, 27505-090